Skip to main content
eScholarship
Open Access Publications from the University of California

Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.

  • Author(s): Gillespie, Eugene J
  • Ho, Chi-Lee C
  • Balaji, Kavitha
  • Clemens, Daniel L
  • Deng, Gang
  • Wang, Yao E
  • Elsaesser, Heidi J
  • Tamilselvam, Batcha
  • Gargi, Amandeep
  • Dixon, Shandee D
  • France, Bryan
  • Chamberlain, Brian T
  • Blanke, Steven R
  • Cheng, Genhong
  • de la Torre, Juan Carlos
  • Brooks, David G
  • Jung, Michael E
  • Colicelli, John
  • Damoiseaux, Robert
  • Bradley, Kenneth A
  • et al.
Abstract

Pathogenic microorganisms and toxins have evolved a variety of mechanisms to gain access to the host-cell cytosol and thereby exert virulent effects upon the host. One common mechanism of cellular entry requires trafficking to an acidified endosome, which promotes translocation across the host membrane. To identify small-molecule inhibitors that block this process, a library of 30,000 small molecules was screened for inhibitors of anthrax lethal toxin. Here we report that 4-bromobenzaldehyde N-(2,6-dimethylphenyl)semicarbazone, the most active compound identified in the screen, inhibits intoxication by lethal toxin and blocks the entry of multiple other acid-dependent bacterial toxins and viruses into mammalian cells. This compound, which we named EGA, also delays lysosomal targeting and degradation of the EGF receptor, indicating that it targets host-membrane trafficking. In contrast, EGA does not block endosomal recycling of transferrin, retrograde trafficking of ricin, phagolysosomal trafficking, or phagosome permeabilization by Franciscella tularensis. Furthermore, EGA does not neutralize acidic organelles, demonstrating that its mechanism of action is distinct from pH-raising agents such as ammonium chloride and bafilomycin A1. EGA is a powerful tool for the study of membrane trafficking and represents a class of host-targeted compounds for therapeutic development to treat infectious disease.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View